(Q40475236)

English

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

phase III clinical trial

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

Paolo Corradini

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Cristina Boschini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Alessandro Busca

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Giuseppe Milone

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

31

object named as

Elena Oldani

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Alessandro Rambaldi

1

object named as

Alessandro Rambaldi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Anna Grassi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Arianna Masciulli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Maria Caterina Micò

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Benedetto Bruno

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Irene Cavattoni

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Stella Santarone

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Roberto Raimondi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Mauro Montanari

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Patrizia Chiusolo

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Domenico Pastore

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Stefano Guidi

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Francesca Patriarca

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Antonio M Risitano

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Giorgia Saporiti

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Elisabetta Terruzzi

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

William Arcese

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Giuseppe Marotta

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Angelo Michele Carella

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Arnon Nagler

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Domenico Russo

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Emilio Paolo Alessandrino

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Giovanni Fernando Torelli

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Rosanna Scimè

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Nicola Mordini

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Rosa Maria Marfisi

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Andrea Bacigalupo

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

28 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1525-1536

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and mu

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological methods to reduce disease recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900200-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)00200-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429297%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40475236&oldid=2199363458"